Patent · US Active

Methods of treatment associated with the granulocyte colony-stimulating factor receptor

US10420748B2 · kind B2 · utility

0Cited by
4References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 28, 2018
Grant dateSep 24, 2019
Priority date—
Expiry dateFeb 28, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/4015
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Some embodiments include methods for treating, preventing, reversing, halting, or slowing the progression of cancer, comprising administering to a subject in need thereof an effective amount of one or more chemotherapeutic agents, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition, wherein at least one of the chemotherapeutic agents is a cytotoxic granulocyte colony-stimulating factor receptor (GCFR) modulator. Methods are also disclosed for treating, preventing, reversing, halting, or slowing the progression of a hematopoietic disorder, comprising administered a therapeutically effective cytotoxic amount of a GCFR modulator to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.